BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35195028)

  • 1. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
    Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
    Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation.
    Raszeja-Wyszomirska J; Macech M; Kolanowska M; Krawczyk M; Nazarewski S; Wójcicka A; Małyszko J
    Ann Transplant; 2023 Aug; 28():e939750. PubMed ID: 37580899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation.
    Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
    Ther Drug Monit; 2023 Feb; 45(1):20-25. PubMed ID: 36127770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients.
    Casas S; Tangprasertchai NS; Oikonomaki K; Mathers S; Sollet ZC; Samara S; Liu J; Burlinson ND; Constantoulakis P; Villard J; Viard T
    HLA; 2024 May; 103(5):e15518. PubMed ID: 38733247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
    Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
    J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
    Ventura-Aguiar P; Ramirez-Bajo MJ; Rovira J; Bañón-Maneus E; Hierro N; Lazo M; Cuatrecasas M; Garcia-Criado MA; Liang N; Swenerton RK; Cofan F; Cucchiari D; Esforzado N; Montagud-Marrahi E; Oppenheimer F; Piñeiro G; Revuelta I; Torregrosa V; Ahmed E; Soboleva K; Kaur N; Zimmermann BG; Al Haj Baddar N; Demko ZP; Escrig C; Tabriziani H; Gauthier P; Billings PR; Amor AJ; Ferrer J; Campistol JM; Diekmann F
    Transplantation; 2022 Aug; 106(8):1690-1697. PubMed ID: 35289777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.
    Jackson AM; Amato-Menker C; Bettinotti M
    Hum Immunol; 2021 Nov; 82(11):850-858. PubMed ID: 34600770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation.
    Li Y; Liang B
    Front Immunol; 2023; 14():1263389. PubMed ID: 37885888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.
    Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A
    Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.
    Oellerich M; Sherwood K; Keown P; Schütz E; Beck J; Stegbauer J; Rump LC; Walson PD
    Nat Rev Nephrol; 2021 Sep; 17(9):591-603. PubMed ID: 34031575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.
    Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M
    Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.
    Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN
    J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.